Horizon Gynecology & Obstetric Associates — a multi-site, 12-physician, 5-nurse practitioner practice comprised of Atlanta Gynecology & Obstetrics and Gynecology & Obstetrics of DeKalb — have chosen the integrated Sage Intergy practice management and Sage Intergy EHR electronic health records system to help improve their practice’s efficiency, enhance coordination of care, and streamline workflow.
[...]
Urodynamix Technologies Ltd. (TSX-V:URO) today announced that it has obtained 510(k) clearance from the U.S. Food and Drug Administration to market the UroNIRS 2000™ Bladder Monitor System - a second generation non-invasive medical device that uses near infrared spectroscopy (NIRS) to aid in the diagnosis of lower urinary tract symptoms (LUTS) in a urology office [...]
Attorney General Martha Coakley’s Office has reached a settlement agreement with Teva Pharmaceutical USA, Inc. (Teva), a North Wales, PA, based pharmaceutical manufacturer to settle a False Claims Act case pending in United States District Court in Boston. Pursuant to the settlement, Teva has paid $7 million to the Massachusetts Medicaid Program.
[...]
Cylene Pharmaceuticals announced that it has initiated a Phase I clinical trial of its oral CK2 protein kinase inhibitor, CX-4945, in patients with advanced solid tumors, Castleman’s disease, or multiple myeloma. The primary endpoints of the oral dose escalating trial are determination of safety, tolerance and PK properties of CX-4945 and to select the appropriate [...]
Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the start of a Phase III clinical trial of Baxter’s GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme’s recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID). The purpose of this clinical [...]
(5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5) (5 out of 5)